The Cannabis ETF (THCX)
ARCA ARCA Primary 
Ancillary Cannabis Stocks to Watch in February: Strong Picks for 2025
Ancillary cannabis stocks continue to gain attention as the industry expands. These companies provide essential products for cultivation, processing, and retail operations. Unlike plant-touching businesses, ancillary stocks face fewer regulatory risks. The U.S. cannabis market was valued at $13.2 billion in 2023 and is expected to reach $40 billion by 2030. This rapid growth fuels demand for hydroponic equipment, lighting systems, and agricultural supplies. Recently, Congress discussed new federal cannabis reform proposals, boosting investor sentiment. Several states, including Florida and Pennsylvania, are considering expanding legalization measures in 2024. These potential changes could drive further market growth and increase demand for ancillary services.
Aurora Cannabis: Remarkable Recovery
Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins and generating solid cash flows. The company reported FQ3 revenues of C$88 million and a significant improvement in adjusted EBITDA to C$23 million, with free cash flow of C$27 million. ACB stock is trading at just 1x forward sales, presenting a buying opportunity, especially on dips, as the company continues to show financial improvement.
Cannabis stocks climb on RFK Jr. approval, Senate marijuana-banking hearing
Cannabis stocks tend to move on speculation around potential federal reforms around pot.
Aurora Cannabis Stock Jumps On 'Record-Breaking' Q3 Earnings
Canada-based global medical cannabis company Aurora Cannabis Inc ACB reported a third-quarter fiscal 2025 net revenue of CA$88.2 million, compared to CA$64.4 million a year ago.
Canadian Cannabis Market Update: Best Stocks to Track in February 2025
The U.S. cannabis industry is experiencing significant growth, presenting opportunities for investors eyeing Canadian cannabis stocks in February 2025. In 2024, the industry generated approximately $40 billion in sales, with projections indicating a rise to nearly $58 billion by 2030. This upward trend is fueled by increasing legalization and consumer acceptance across various states. Notably, New York's legal cannabis market has expanded rapidly, with retail sales reaching $1 billion in 2024. Such developments underscore the sector's robust potential.
Best Ancillary Cannabis Stocks for February: Strong Picks in Real Estate, Tech, and Equipment
The U.S. cannabis industry continues expanding, creating opportunities for companies that support the sector. In 2023, legal cannabis sales reached $34 billion, with projections exceeding $50 billion by 2028. Ancillary cannabis stocks provide services such as real estate, technology, and equipment without directly handling the plant. These businesses are essential for industry growth. Recent headlines suggest more states are considering legalization, increasing demand for cannabis infrastructure. Federal reform discussions also continue, fueling speculation about potential policy shifts. As the industry expands, investors look for stocks benefiting from this growth.
Top Canadian Cannabis Stocks in 2025: What to Watch in January
The Canadian cannabis industry has established itself as a major player in the global market, particularly with its strategic U.S. expansions. As of 2025, the U.S. cannabis industry is valued at approximately $32 billion, with projections of reaching $57 billion by 2030. Recent news about federal legalization prospects, including discussions on banking reform and the SAFE Banking Act, has created optimism. Canadian companies closely monitor these developments, aiming to capitalize on potential U.S. market opportunities. This week, top Canadian cannabis stocks, including Tilray, Canopy Growth, and Village Farms, present intriguing prospects due to their diversified operations and growth strategies.
3 Big Name Marijuana Stocks In The Cannabis Sector
As the entirety of the cannabis industry further evolves, 2025 aims to be a key year for marijuana stocks. Stronger efforts on legalization across various states and countries. As well as the change in public perception of the plant. Which has gradually transformed the cannabis sector into a burgeoning market. Investors are starting to acknowledge the potential of marijuana stocks with all the current industry success. Much of this is fueled by the prospects of mainstream acceptance and integration into the global economy.
Top Cannabis REITs Driving Industry Expansion in 2025
The cannabis industry remains a focal point for investors, especially with recent federal developments. Last week, a bill proposing federal cannabis legalization was reintroduced in Congress, reigniting optimism for the sector's future. If passed, this legislation could address federal banking restrictions and support cannabis businesses. The US cannabis market is projected to reach $41.5 billion by 2025, according to industry reports. With 39 states already permitting medical or recreational cannabis, the potential for federal reform could accelerate growth. This week, these developments make cannabis-focused real estate investment trusts (REITs) particularly intriguing. REITs offer exposure to this rapidly growing sector while providing consistent dividend income.
2 Marijuana Stocks To Follow In The Cannabis Sector
Top cannabis investors are trying to keep a positive outlook for future trading. Relying on volatility to bring the sector up at certain times is not always the ideal way to invest and trade. Yet when the market is behaving in such as way the only option is to sell or adjust. Most have transitioned to taking gains at every volatile pop. Often those who have shares in marijuana stocks face low-level trading more upward trading. Which is the majority caused by volatility.
Top Canadian Cannabis Companies Poised for Market Growth in 2025
The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are projected to reach $50 billion by 2026. This impressive growth is fueled by increasing state-level legalization and the potential for federal reform. Recent headlines, including bipartisan efforts to reschedule cannabis and banking legislation advancements, have renewed investor optimism. As Canadian cannabis companies eye the lucrative U.S. market, their innovative strategies and cross-border partnerships position them for potential success. This week, top Canadian cannabis stocks, including Aurora Cannabis, Cronos Group, and Sundial Growers, are worth watching closely.
How Federal Legalization Could Boost Ancillary Cannabis Stocks in 2025
The cannabis industry continues to grow in prominence as legalization efforts expand across the United States. Ancillary cannabis companies, which support the sector without directly touching the plant, are becoming pivotal in driving this growth. These companies often manufacture essential products like lighting, irrigation systems, and other equipment critical for cannabis cultivation. In 2025, they stand at the forefront of a transformative era, fueled by advancing legislation and innovative technology.
